NTT Enhancing INDYCAR Fan Experience and Safety at Indianapolis Motor Speedway

INDIANAPOLIS -Wednesday 27 May 2020 [ AETOS Wire ]

(BUSINESS WIRE)-- In preparation for the rescheduled 104th Indianapolis 500 presented by Gainbridge, NTT Corporation (NTT) today announced enhancements to Indianapolis Motor Speedway (IMS) that will accelerate smart technologies to improve the INDYCAR fan experience and safety when the Greatest Spectacle in Racing returns Sunday, Aug. 23, 2020.

“We are excited that when fans arrive at IMS for the Indy 500 they will be greeted with an improved, world-class and one-of-a-kind trip to the Racing Capital of the World,” said Mark Miles, Penske Entertainment Corp. President & CEO. “The future of sports will be driven by the ability to use technology to enhance fan experience, safety and convenience. NTT is helping IMS and INDYCAR find new and exciting ways to blend tradition with innovation and ultimately preserve and further The Greatest Spectacle in Racing’s history of discovery and progress.”

NTT will leverage the company’s Accelerate Smart data platform to power a 100-foot wide Media Wall at the base of the landmark Pagoda building, which will provide fans with access to data-driven race insights in real-time. The debut of the highly visible Media Wall will capture fans’ attention with 3D experiences, visualization of 143 data points from every car and multiple live feeds throughout the track. NTT’s Accelerate Smart platform will also use machine learning to indicate where cars should be on the track and predict their next move, while AI will pinpoint the best on-track battles and highlight head-to-head matchups in real-time with pit predictions, top speeds and more.

“NTT’s Accelerate Smart platform is super-charging efforts to significantly enhance the fan-experience at IMS. At this year’s Indy 500, the platform’s statistics and information will power a transformed Pagoda Plaza experience, providing key and engaging competition insights never previously available to in-venue fans in real time,” said Indianapolis Motor Speedway President, J. Douglas Boles. “In addition, NTT will also boost our safety and security grid, contributing to the well-being of spectators and event participants at the world’s largest single-day sporting event.”

At IMS, NTT’s Accelerate Smart solution includes safety and security measures that will offer more effective event security operations and oversight. Data analytics and insights will provide crowd and vehicle congestion detection and alerts that predict rates based on trends at the gates and tunnels. The digital-enabled, enhanced safety and security will establish a model to promote a consistent experience at IMS, as well as all INDYCAR venue events.

“The future of sport means providing fans with digital-first content, better access to technology and leveraging venues, such as IMS, to engage fans through new channels,” said Akira Shimada, Senior Executive Vice President, NTT. “Our Accelerate Smart data platform allows us to digitally transform INDYCAR’S fan engagement to retain its standing as a leader in motorsports, while also creating a safer race day experience.”

Penske and IMS leadership have made connectivity a key theme of investment to allow fans access to as much data and information in real-time as possible. As part of the digital focus, NTT has also evolved the INDYCAR Mobile app powered by NTT DATA to provide fans a second screen to view live in-car camera video during races, track weather forecasts, create and follow fantasy teams, watch on-demand highlights and more.

NTT’s is committed to accelerating the future of smart racing and creating the next generation of INDYCAR fans who want to enjoy the sport through a more digital experience. This is in part why NTT, a global information technology and communications leader, has been the title sponsor of the NTT INDYCAR SERIES since 2019, as well as the Official Technology Partner of INDYCAR, the NTT INDYCAR SERIES, Indianapolis Motor Speedway, Indianapolis 500 and NASCAR’s the Brickyard 400.

About NTT

NTT believes in resolving social issues through our business operations by applying technology for good. We help clients accelerate growth and innovate for current and new business models. Our services include digital business consulting, technology and managed services for cybersecurity, applications, workplace, cloud, data center and networks all supported by our deep industry expertise and innovation.

As a top 5 global technology and business solutions provider, our diverse teams operate in 88 countries and regions and deliver services to over 190 of them. We serve 85% of Fortune Global 100 companies and thousands of other clients and communities around the world.
For more information on NTT, visit www.global.ntt/.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200521005270/en/

Contacts
Media Contact
Drew Wilson, NTT DATA Services
drew.wilson@nttdata.com
469.486.8653

Permalink : https://www.aetoswire.com/news/ntt-enhancing-indycar-fan-experience-and-safety-at-indianapolis-motor-speedway/en

Amazon Announces Five New Utility-Scale Solar Projects to Power Global Operations in China, Australia, and the U.S.

SEATTLE -Tuesday 26 May 2020 [ AETOS Wire ]

The five projects include Amazon’s first renewable energy project in China, second in Australia, second and third in Ohio, and 12th in the Commonwealth of Virginia, with a combined 615 MW of additional renewable capacity and an expected generation of 1.2 million MWh of energy annually, or enough to power 113,000 average U.S. homes

Projects will supply renewable energy to the fulfillment centers and AWS data centers that support millions of customers globally

Globally, Amazon has 91 renewable energy projects that have the capacity to generate over 2,900 MW and deliver more than 7.6 million MWh of energy annually, further supporting the Company’s Climate Pledge commitment to meet the Paris Agreement 10 years early and reach net zero carbon by 2040

(BUSINESS WIRE)-- Today, Amazon (NASDAQ: AMZN) announced five new renewable energy projects in China, Australia and the U.S. that further support Amazon’s commitment to reach 80% renewable energy by 2024 and 100% renewable energy by 2030 (and potentially as early as 2025), as well as to reach net zero carbon by 2040.

Amazon’s first renewable energy project in China is a 100 megawatt (MW) solar project in Shandong. Once complete, the project is expected to generate 128,000 megawatt hours (MWh) of clean energy annually.

Amazon’s second renewable energy project in Australia is a 105 MW solar project in New South Wales. This project will have the capacity to generate 250,000 MWh of clean energy each year, which is enough to power the equivalent of 40,000 average Australian homes.

Amazon’s newest renewable energy projects in the U.S. include two new projects in Ohio, a 200 MW solar project and an 80 MW solar project. Additionally, a new 130 MW solar project in Virginia brings the total number of renewable energy projects in the Commonwealth to 12. Once enabled, these three U.S.-based projects have the capacity to power the equivalent of 69,000 average U.S. homes each year.

When complete, the five new Amazon renewable energy projects totaling 615 MW of installed capacity will supply approximately 1.2 million MWh of additional renewable energy to the company’s fulfillment network and Amazon Web Services (AWS) data centers, which power Amazon and millions of customers globally.

To date, Amazon has announced 31 utility-scale wind and solar renewable energy projects and 60 solar rooftops on fulfillment centers and sort centers around the globe. Together, these projects totaling over 2,900 MW of capacity will deliver more than 7.6 million MWh of renewable energy annually, enough to power 680,000 U.S. homes.

“As a signatory to The Climate Pledge, we’re committed to meeting the goals of the Paris Agreement 10 years early and reaching net zero carbon across Amazon by 2040,” said Kara Hurst, Vice President of Sustainability, Amazon. “These five new renewable energy projects are a critical part of our roadmap to reach this goal. In fact, we believe it is possible to reach 100% renewable energy by 2025, five years ahead of the goals we announced last fall. While this will be challenging, we have a credible plan to get there.”

“Virginia’s energy future is bright. Through investments in clean energy we can reduce carbon emissions and create jobs to help drive long-term economic development,” said Virginia Senator Jennifer L. McClellan. “The announcement of this new Amazon solar project helps the Commonwealth meet our climate goals and contributes to our economic growth. The Virginia Clean Economy Act will help to drive more clean energy investments like this, to make Virginia a national hub for clean energy jobs.”

“Clean energy job creation is a crucial driver for long-term economic development in the Commonwealth,” said Virginia Delegate Richard C. Sullivan Jr. “I am pleased that Amazon continues to invest in Virginia’s clean energy future. The Virginia Clean Economy Act has put us on a path to 100 percent clean energy, and companies like Amazon are critical to helping us achieve that goal.”

Visit Amazon’s sustainability website for information and sustainability metrics that share the progress the company is making towards reaching The Climate Pledge. The goals, commitments, investments, and programs build on Amazon’s long-term commitment to sustainability through existing innovative programs, including Shipment Zero – Amazon’s vision to make all shipments net zero carbon, with 50% net zero carbon by 2030; sustainable packaging initiatives like Frustration-Free Packaging and Ship in Own Container, which have reduced packaging waste by 25% since 2015; renewable energy programs; investments in the circular economy with the Closed Loop Fund; and numerous other initiatives happening every day and led by teams across Amazon.

About Amazon

Amazon is guided by four principles: customer obsession rather than competitor focus, passion for invention, commitment to operational excellence, and long-term thinking. Customer reviews, 1-Click shopping, personalized recommendations, Prime, Fulfillment by Amazon, AWS, Kindle Direct Publishing, Kindle, Fire tablets, Fire TV, Amazon Echo, and Alexa are some of the products and services pioneered by Amazon. For more information, visit amazon.com/about and follow @AmazonNews.

About Amazon Web Services

For 14 years, Amazon Web Services has been the world’s most comprehensive and broadly adopted cloud platform. AWS offers over 175 fully featured services for compute, storage, databases, networking, analytics, robotics, machine learning and artificial intelligence (AI), Internet of Things (IoT), mobile, security, hybrid, virtual and augmented reality (VR and AR), media, and application development, deployment, and management from 76 Availability Zones (AZs) within 24 geographic regions, with announced plans for nine more Availability Zones and three more AWS Regions in Indonesia, Japan, and Spain. Millions of customers—including the fastest-growing startups, largest enterprises, and leading government agencies—trust AWS to power their infrastructure, become more agile, and lower costs. To learn more about AWS, visit aws.amazon.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200521005212/en/

Contacts

Amazon.com, Inc.
Media Hotline
Amazon-pr@amazon.com
www.amazon.com/pr

Permalink : https://www.aetoswire.com/news/amazon-announces-five-new-utility-scale-solar-projects-to-power-global-operations-in-china-australia-and-the-us/en

Secure Code Warrior® Answers the Call From Zoom Video Communications

Secure Code Warrior’s ‘start left’ approach to secure coding amplifies Zoom’s commitment to software security

SYDNEY & BOSTON & LONDON -Tuesday 26 May 2020 [ AETOS Wire ]

(BUSINESS WIRE)-- Global secure coding company Secure Code Warrior® today announced it had been selected by Zoom Video Communications, Inc. (NASDAQ: ZM), to implement its online secure coding platform as part of Zoom’s ongoing strategy to enhance their developers’ secure coding best practices.

"With an upturn in remote working, online communication and collaboration, it is more vital than ever to ensure the software powering effective remote teams is private and secure”, said Pieter Danhieux, Secure Code Warrior Co-Founder, CEO, and Chairman. “We're striving to assist companies all over the world in achieving industry-leading best practices by shipping secure code with confidence. It has been excellent to see Zoom's efforts to quickly scale a first-class security program, and we're excited to be partnering with their software engineers to further build security in their DNA."

Richard Farley, CISO at Zoom said, “It is critical that our development teams are security-aware, and that every individual continues their journey to become secure coders. Working with Secure Code Warrior will ensure our teams have the applied skills and expertise to mitigate common cybersecurity risks, especially as we see hyper-growth in our user adoption rate and solidify our position as the best-in-class web conferencing tool.”

“Zoom has reacted swiftly and transparently to tackle any security and privacy concerns with its platform. Their recently announced ‘90-day Security Plan’ outlines the work they have been doing, and their achievements to date. The introduction of Secure Code Warrior’s platform will continue that progress by providing defensive tournaments, training, certification, and developer-first tools that enable writing secure software,” added Danhieux.

ABOUT SECURE CODE WARRIOR
Founded in 2015 by global cybersecurity experts Pieter Danhieux and Dr. Matias Madou, Secure Code Warrior is an online secure coding platform that helps developers think and act with a security mindset every day. It is role-specific for developers, using a mix of gamification techniques to aid learning and engagement. It supports a wide range of languages and frameworks that power modern software, including web apps and services, API, mobile, IoT technology, and legacy systems.

Customers include financial institutions, telecommunications providers, and technology companies across the globe. Learn more at www.securecodewarrior.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200519005395/en/

Contacts

Nick Flude
CMO, Secure Code Warrior
nflude@securecodewarrior.com
+61 416 140 298

Permalink : https://www.aetoswire.com/news/secure-code-warriorreg-answers-the-call-from-zoom-video-communications/en

Blue Ocean Robotics Acknowledged with Robot Product Leadership Award 2020 for Virus-Killing UVD Robots

Frost & Sullivan “Best Practices Award” Recognizes Impact of Company’s UVD Robots in Disinfecting Against Viruses like COVID-19 as well as Company’s Other Service Robots; GoBe Robots and PTR Robots

ODENSE, Denmark -Tuesday 26 May 2020 [ AETOS Wire ]

(BUSINESS WIRE)-- Today, Blue Ocean Robotics announced that it has been selected by Frost & Sullivan for its Best Practice “2020 European Professional Service Robots Product Leadership” Award. The recognition was earned primarily based on the company’s work with subsidiary UVD Robots, which combines autonomous robot technology with ultraviolet light to disinfect against viruses like COVID-19.

A subsidiary of Blue Ocean Robotics, Denmark-based UVD Robots’ innovative solution has been proven to eliminate pathogens within 10-15 minutes in a patient room. The company’s self-driving, disinfecting robots have been rolled out to more than 50 countries worldwide, to date.

“Being recognized by Frost & Sullivan with a 'Best Practice Award' pays tribute to the heart, passion and drive we dedicate to creating innovation, development and commercial success,” said Blue Ocean Robotics CEO Claus Risager. “We are very proud to develop robots that not only help solve the world's problems, but are also solid and lucrative investments for our owners.”

Frost & Sullivan Best Practices Awards are presented to companies that encourage significant growth in their industries, have identified emerging trends before they became the standard in the marketplace, and have created advanced technologies to catalyze and transform industries.

“Blue Ocean Robotics’ flagship product, UVD Robots, especially enables hospitals to reduce disease transmission by killing 99.99 percent of bacteria and microorganisms,” said Rohit Karthikeyan, Industry Manager with Frost & Sullivan. “It is the first and only autonomous mobile robot that disinfects a variety of surfaces using UV-C light, giving it superior utility over competing solutions. Uniquely, the UVD robot can be easily controlled with a tablet.”

About Blue Ocean Robotics
Blue Ocean Robotics develops, produces and sells professional service robots in healthcare, hospitality, construction, agriculture, and other global markets. The portfolio of robots includes the brands; UVD Robots, a mobile robot for disinfection; GoBe Robots, a mobile telepresence robot for communication; and PTR Robots, a mobile robot for safe patient handling and rehabilitation. Each robot is placed in its own subsidiary-venture company, making Blue Ocean Robotics the world’s first Robot Venture Factory.

Download press kit here.

Photos/Multimedia Gallery Available: https://www.businesswire.com/news/home/52225159/en

Contacts

Merima Cikotic
Blue Ocean Robotics
+45 71-99-56-06
mc@blue-ocean-robotics.com


Permalink : https://www.aetoswire.com/news/blue-ocean-robotics-acknowledged-with-robot-product-leadership-award-2020-for-virus-killing-uvd-robots/en

Boehringer Ingelheim and Lilly to collaborate with Duke Clinical Research Institute on a pragmatic trial examining empagliflozin’s effects following an acute myocardial infarction

INGELHEIM, Germany & INDIANAPOLIS, US -Tuesday 26 May 2020 [ AETOS Wire ]

    Ischemic heart disease, including myocardial infarction, is the leading cause of death in the world1
    EMPACT-MI is the first trial in the SGLT2 inhibitor class to investigate the prevention of heart failure after acute myocardial infarction in adults with and without diabetes
    The trial is part of the EMPOWER clinical trial program, the broadest and most comprehensive of any SGLT2 inhibitor, exploring the impact of empagliflozin on the lives of people across the spectrum of cardio-renal-metabolic conditions

(BUSINESS WIRE)-- Boehringer Ingelheim and Eli Lilly and Company (NYSE:LLY) today announced an academic research collaboration with the Duke Clinical Research Institute (DCRI) on a new trial, EMPACT-MI (EMPAgliflozin for the prevention of Chronic heart failure and morTality after an acute Myocardial Infarction). The collaboration will investigate whether empagliflozin can improve outcomes and prevent heart failure in adults with and without diabetes who have had an acute myocardial infarction, more commonly known as a heart attack. This randomized clinical trial will be conducted, analyzed and reported in partnership with the DCRI, with Boehringer Ingelheim and Lilly providing funding.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200526005445/en/

EMPACT-MI will include approximately 3,300 adults across at least 16 countries who have had an acute myocardial infarction. The primary endpoint of the trial is to assess the effect of empagliflozin on all-cause mortality and hospitalization for heart failure. The trial will be part of the EMPOWER program, the broadest and most comprehensive clinical trial program exploring the impact of empagliflozin on the lives of people with cardio-renal-metabolic conditions.

“This collaboration represents an important step in understanding how to safeguard and protect the lives of patients with acute myocardial infarction,” said Adrian Hernandez, M.D., M.H.S., Co-Chair of the EMPACT-MI trial and DCRI Executive Director. “Myocardial infarction is the leading cause of death in cardiology, and this is the first trial in the SGLT2 inhibitor class to investigate the potential to increase survival and decrease progression to heart failure in people who have had a recent myocardial infarction.”

Javed Butler, M.D., M.P.H., M.B.A., Chair of the EMPACT-MI trial and Professor and Chairman of the Department of Medicine at the University of Mississippi, added, “We are delighted to lead the EMPACT-MI trial to find out whether empagliflozin could become a new standard of care option to improve the outcomes and lives of people with acute myocardial infarction.”

Pragmatic clinical trials focus on the relationship between treatments and outcomes in real-world health system practice. This partnership will leverage the DCRI’s experience in pragmatic trials by implementing innovative and efficient trial elements, including remote follow-up and a focused data collection approach, which enable a strong patient focus while maintaining high data quality.

“We are pleased to collaborate with the Duke Clinical Research Institute on the EMPACT-MI trial to investigate the potential to increase survival and prevent heart failure from developing in adults who have had a heart attack. Despite current therapies, these patients have a high residual risk that could be addressed by the multiple benefits we have observed with SGLT2 inhibition,” said Waheed Jamal, M.D., Corporate Vice President and Head of CardioMetabolic Medicine, Boehringer Ingelheim.

“The EMPACT-MI trial is part of our broad and comprehensive clinical development program, which aims to explore how empagliflozin can improve health outcomes and fill therapeutic gaps for a broad range of patients suffering from cardio-renal-metabolic conditions,” said Jeff Emmick, M.D., Ph.D., vice president, Product Development, Lilly.

About the Duke Clinical Research Institute
The DCRI, part of the Duke University School of Medicine, is the largest academic clinical research organization in the world. Its mission is to develop and share knowledge that improves the care of patients through innovative research. The institute conducts groundbreaking multinational clinical trials, manages major national patient registries, and performs landmark outcomes research. DCRI research spans multiple disciplines, from pediatrics to geriatrics, primary care to subspecialty medicine, and genomics to proteomics. The DCRI also is home to the Duke Databank for Cardiovascular Diseases, the largest and oldest institutional cardiovascular database in the world, which continues to inform clinical decision-making 40 years after its founding.

About EMPACT-MI
EMPACT-MI (EMPAgliflozin for the prevention of Chronic heart failure and morTality after an acute Myocardial Infarction) is a streamlined, randomized, blinded, placebo-controlled, multi-center trial exploring the efficacy and safety of empagliflozin in adults hospitalized with an acute myocardial infarction.

About EMPOWER

The EMPOWER program reinforces the long-term commitment of the Boehringer Ingelheim and Eli Lilly and Company Alliance to improve outcomes for people living with cardiovascular and renal disease. EMPOWER is one of the largest cardiovascular clinical trial programs for an SGLT2 inhibitor to date with more than 13,000 adults worldwide. The aim of the program is preventing major clinical cardiovascular and renal outcomes that affect millions of adults worldwide as well as families and healthcare systems.

In addition to EMPACT-MI, the development program encompasses:

    EMPEROR reduced, in adults with chronic heart failure with reduced ejection fraction to prevent cardiovascular death and hospitalization due to heart failure
    EMPEROR preserved, in adults with chronic heart failure with preserved ejection fraction to prevent cardiovascular death and hospitalization due to heart failure
    EMPULSE, in adults hospitalized for acute heart failure to improve clinical and patient reported outcomes
    EMPA-KIDNEY, in adults with established chronic kidney disease to reduce the progression of kidney disease and the occurrence of cardiovascular death
    EMPERIAL reduced, in adults with chronic heart failure with reduced ejection fraction to improve functional ability and patient reported outcomes
    EMPERIAL preserved, in adults with chronic heart failure with preserved ejection fraction to improve functional ability and patient reported outcomes
    EMPA-REG OUTCOME®, in adults with type 2 diabetes and established cardiovascular disease to prevent major adverse cardiovascular events, including cardiovascular death
    EMPRISE, a comparative effectiveness and safety study in routine clinical care.

About Acute Myocardial Infarction
Ischemic heart disease, including acute myocardial infarction (heart attack), is the leading cause of death and disability in the world,1 with over 7 million acute myocardial infarctions occurring every year.2 People who suffer an acute myocardial infarction are at a high risk of heart failure and death. Heart attacks occur when the blood supply to an area of the heart is blocked by a blood clot or by atherosclerosis (fatty deposits or plaques lining vessel walls) causing heart tissue to die. Rapid diagnosis and treatment to restore blood flow through the affected vessel are vital to save as much of the heart tissue as possible.3

About Heart Failure
Heart failure is a progressive, debilitating and potentially fatal condition that occurs when the heart cannot supply adequate circulation to meet the body’s demands for oxygenated blood or to do so requires increased blood volume leading to fluid accumulation (congestion) in the lungs and peripheral tissues.4 It is a widespread condition affecting 60 million people worldwide and expected to increase as the population ages.5 Heart failure is highly prevalent in people with diabetes;6 however, approximately half of all people with heart failure do not have diabetes.3,7

The empagliflozin heart failure program was initiated based on data from the EMPA-REG OUTCOME® trial, which assessed the effect of empagliflozin (10 mg or 25 mg once daily) added to standard of care compared with placebo added to standard of care.8 EMPA-REG OUTCOME® was the first SGLT2 inhibitor trial to show a relative risk reduction in cardiovascular death in adults with type 2 diabetes and established cardiovascular disease. This population was comprised of more than 45% of adults with a prior myocardial infarction.8

About Empagliflozin
Empagliflozin (marketed as Jardiance®) is an oral, once daily, highly selective sodium glucose cotransporter 2 (SGLT2) inhibitor and the first type 2 diabetes medicine to include cardiovascular death risk reduction data in its label in several countries.9,10,11

Inhibition of SGLT2 with empagliflozin in people with type 2 diabetes and high blood sugar levels prevents sugar being re-absorbed by the kidneys, leading to the excretion of excess sugar in the urine. In addition, initiation of empagliflozin also prevents salt being re-absorbed, leading to increased excretion of salt from the body and reducing the fluid load of the body’s blood vessel system (i.e. intravascular volume). Empagliflozin induces changes to the sugar, salt and water metabolism in the body that may contribute to the reductions in cardiovascular death observed in the EMPA-REG OUTCOME® trial.12

Please click on the following link for ‘Notes to Editors’ and ‘References’ https://www.boehringer-ingelheim.com/press-release/dcri-collaboration-empact-mi



View source version on businesswire.com: https://www.businesswire.com/news/home/20200526005445/en/

Contacts

Stefanie Molkenthin
Product Communication Manager
Boehringer Ingelheim
Email: press@boehringer-ingelheim.com
Phone: +49 (6132) 77 172209

Stephan Thalen
Global Business Communications
Lilly Diabetes
Email: stephan.thalen@lilly.com
Phone: +1 (317) 276 8304

Kaitlin Jansen
DCRI Communications
Email: kaitlin.jansen@duke.edu
Phone: +1 (704) 995 2384

Susan Landis
DCRI Communications
Email: susan.landis@duke.edu
Phone: +1 (919) 668 5769

Permalink : https://www.aetoswire.com/news/boehringer-ingelheim-and-lilly-to-collaborate-with-duke-clinical-research-institute-on-a-pragmatic-trial-examining-empagliflozinrsquos-effects-following-an-acute-myocardial-infarction/en

Announcing Berkeley Global!

Leading educational institution brings students from around the world



BERKELEY, Calif.-Tuesday 26 May 2020 [ AETOS Wire ]

(BUSINESS WIRE)-- UC Berkeley Extension is proud to announce the launch of UC Berkeley Global. This new brand expands UC Berkeley’s long-standing mission to provide educational access to its local and international global communities.

“Now more than ever, we must realize that our lives are interconnected, and that education has always been the most effective way to develop cultural humility,” says Dean Diana Wu. “We define global as a mindset rather than a geography. We’re seeking students who want to expand beyond their comfort zones and learn from peers here in Berkeley and across the world.”

Eligible students can apply for Berkeley Global’s many programs across dozens of subjects in science, technology, business, and arts & letters. Formats range from online self-paced courses to full-time study abroad, as well as a new version called “Live Online.” This modality combines the convenience of online study with instructor-led sessions.

“It’s important that we meet a variety of student needs,” says Wu. “We have programs for high schoolers seeking an American educational experience to seasoned professionals upskilling for a major career transition. UC Berkeley Global students can take courses right alongside other Berkeley students with some of the top faculty in the world, or study a specialized topic from industry experts. Flexibility is an important part of the student journey.”

About Berkeley Global

Berkeley Global extends the reach of UC Berkeley’s impact by providing access and opportunities to a broad and diverse community of international learners. Students come from all over the world to study at the top-ranked public university.

About UC Berkeley Extension

Founded in 1891, UC Berkeley Extension is the continuing education branch of the University of California, Berkeley. Today, Extension offers more than 2,000 courses each year, including online courses, along with more than 70 professional certificates and specialized programs of study. Free and low-cost public events are also frequently held as part of Extension’s service to the local community.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200519005247/en/

Contacts
Sarah Benzuly
Director of Creative Services
Marketing Department
Berkeley Global | UC Berkeley Extension
sbenzuly@berkeley.edu
510/643-1087




Permalink : https://www.aetoswire.com/news/announcing-berkeley-global/en

AGCO Agriculture Foundation Launches COVID-19 Aid Program with $100,000 Donation to the World Food Program USA

Inaugural Grant Addresses Food Security and Key Supplies in Africa and Latin America

DULUTH, Ga. -Tuesday 26 May 2020 [ AETOS Wire ]

(BUSINESS WIRE)-- The AGCO Agriculture Foundation (AAF), a private foundation committed to ending hunger through sustainable agricultural development, today announced the launch of its COVID-19 Aid Program with a $100,000 grant to the World Food Program USA (WFP USA) in support of the United Nations World Food Programme’s (WFP) COVID-19 emergency response.

The AAF COVID-19 Aid Program’s inaugural grant to WFP USA will support the WFP, the leading humanitarian agency fighting hunger worldwide, to continue to deliver food and critical supplies at full capacity. Our donation will focus on the most vulnerable populations in Africa and Latin America.

“The urgency of hunger worldwide has become even more critical with the addition of the coronavirus, and we are directing our global support to the World Food Program USA in support of WFP’s COVID-19 relief efforts. Our funding will help monitor the impact of the pandemic, pre-position food and medical supplies in vulnerable communities in Africa and Latin America, as well as lend support to newly established supply chain coordination cells on the ground,” says Lucinda Smith, Board Chairman, AGCO Agriculture Foundation.

“We are grateful to AGCO Agriculture Foundation for their generous donation and support to raise much needed funding for WFP’s COVID-19 response efforts,” said Barron Segar, World Food Program USA President and CEO. “WFP serves as the logistics and transportation backbone to the humanitarian community and AAF’s contribution is critical to ensuring WFP can get lifesaving food and supplies to millions of the most vulnerable people.”

The AAF is matching donations up to $100,000 made at this link: www.wfpusa.org/aaf-match.

“We would like to invite our stakeholders to contribute to the World Food Program USA global emergency response to support this critical need,” said Metti Richenhagen, Managing Director, AGCO Agriculture Foundation.

“The AGCO Agriculture Foundation has launched the COVID-19 Aid Program with total funding of $500,000 and is also making grants to local non-profit organizations focused on the prevention and relief of hunger in the communities where we live and work across the globe.”

About the AGCO Agriculture Foundation (AAF)

The AGCO Agriculture Foundation (AAF), initiated by AGCO Corporation (NYSE: AGCO) in 2018, is a private foundation with the vision to prevent and relieve hunger. The foundation initiates impactful programs that support food security, foster sustainable agricultural development and build needed agricultural infrastructure in marginalized farming communities. AAF is domiciled in Vaduz, Liechtenstein and operations are managed from Duluth, Georgia, USA. For more information, please visit https://www.agcocorp.com/commitment/sustainability/focus-areas/communities.html.

About World Food Program USA

World Food Program USA is the recognized leader in America’s pursuit to end global hunger, inspiring citizens to do everything in their power to create a zero-hunger world. WFP USA works with U.S. policymakers, corporations, foundations and individuals to generate financial and in-kind resources for the United Nations World Food Programme to feed families in need around the world and to develop policies necessary to alleviate global hunger. To learn more about WFP USA’s mission, please visit us at www.wfpusa.org.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200521005211/en/

Contacts
Metti Richenhagen
Managing Director, AGCO Agriculture Foundation
AGCOagriFoundation@agcocorp.com


Permalink : https://www.aetoswire.com/news/agco-agriculture-foundation-launches-covid-19-aid-program-with-100000-donation-to-the-world-food-program-usa/en